Oncology Tube
@oncologytube
Followers
17K
Following
9K
Statuses
140K
Produce, Find, and Distribute the latest and highest quality multimedia to oncologists, hematologists and researchers.
Temecula, CA
Joined September 2009
FDA approves Adcetris / brentuximab vedotin + lenalidomide & rituximab in relapsed or refractory LBC VIDEO: @pfizer_news
@PfizerOncMed
@PfizerMed
@TakedaOncology
@TakedaPharma
@FDAOncology
@FDA_Drug_Info
@FDA
#FDA #BrentuximabVedotin #Lenalidomide #Rituximab #LBCL #Cancer #Oncology #ClinicalTrial #ECHELON3 #CancerResearch #Healthcare #MedicalNews #Pharma #PatientCare #Lymphoma #TreatmentOptions #MedicalInnovation #OncologyTube
@OncoAlert
0
0
2
@SuyogCancer @ASCO @KoheiShitara @VPrasadMDMPH @OncoAlert Disappointing for sure. We put together more stats and a video from the info on the table you shared:
0
0
1
@SuyogCancer @KoheiShitara @ASCO @Larvol Infographic showing CAR-T GI trials average mPFS 3.59 and average no. patients 19.53 VIDEO & Article Here:
0
0
1
VIDEO: FDA Approves Datopotamab Deruxtecan / Datroway from Eli Lilly in Treatment for Unresectable or Metastatic HR-Positive, HER2-Negative Breast Cancer VIDEO LINK: @FDAOncology #BreastCancer #Datopotamab #Deruxtecan #ClinicalTrials, #CancerTreatment, #Oncology #Healthcare, #MedicalNews, #PatientCare, #CancerResearch, #OncologyTube, #TROPIONBreast01, #Pharma, #Medication, #HealthInnovation, #CancerAwareness, #SurvivalRates, #SideEffects, #DrugApproval, #BreastCancerAwareness
0
0
0
Can Imlunestrant Change the Future of Breast Cancer Treatment? Insights from #SABCS24 with Virginia Kaklamani, MD ARTICLE: @AACR @UTHealthSA @VKaklamani #EMBER3Trial #Imlunestrant #SERD #BreastCancer #ERpositive #HER2negative #AdvancedBreastCancer #OncologyResearch #CancerTreatment #Phase3Trial #ESR1Mutations #ProgressionFreeSurvival #Abemaciclib #OralTherapy #EndocrineTherapy #ClinicalTrialResults #CancerCare #OncologyUpdates
0
1
1
FDA Approves Daiichi Sankyo Datopotamab / Datroway for HR-positive, HER2-negative Advanced Breast Cancer - Key Trial Data @EUdaiichisankyo @FDAOncology @FDA_Drug_Info #FDAApproval #Datroway #BreastCancer #HRpositive #HER2negative #MetastaticCancer #Oncology #CancerResearch #ClinicalTrial #TROPIONBreast01 #TargetedTherapy #CancerTreatment #DaiichiSankyo #PrecisionMedicine #MedicalNews for more info
0
0
0
@EliLillyandCo Imlunestrant EMBER-3 Trial Results: Is this the Next-Gen SERD for ER+ Breast Cancer? - Expert Analysis @VKaklamani @AACR @UTHealthSA #EMBER3Trial #Imlunestrant #SERD #BreastCancer #ERpositive #HER2negative #AdvancedBreastCancer #OncologyResearch #CancerTreatment #Phase3Trial #ESR1Mutations #ProgressionFreeSurvival #Abemaciclib #OralTherapy #EndocrineTherapy #ClinicalTrialResults #CancerCare #OncologyUpdates
0
0
0
InfoGraphic: IDH1+ & FGFR2+ #BiliaryTractCancer patients might fare worse with immunotherapy added to first-line #GemCis treatment! EXPERT VIDEO ANALYSIS: @ASCO #GI25 @NateraGenetics #ASCO2025 #Immunotherapy #PrecisionMedicine #Oncology #CancerResearch #mBTC #Genomics #ClinicalOutcomes #IDH1 #FGFR2 #RealWorldData #SurvivalRates #CancerTreatment
0
0
2
New SOC Encorafenib + cetuximab (EC) BREAKWATER BRAF V600E-Mutant Metastatic Colorectal Cancer @ASCO #GI25 @skopetz
@MDAndersonNews #ColorectalCancer #Encorafenib #Cetuximab #EC #BREAKWATER #BRAFV600E #MetastaticColorectalCancer #ColorectalCancer #CancerTreatment #Oncology #CancerResearch #NewStandardOfCare #PrecisionMedicine #TargetedTherapy #CancerInnovation #ClinicalTrial #MedicalBreakthrough #CancerAwareness #Healthcare #OncologyUpdates
0
0
0
FDA Alert Capecitabine & The Critical Role of DPD Deficiency Testing Before Treatment @US_FDA @FDAMedWatch #FDASafetyAlert #DPDDeficiency #Capecitabine #5FU #CancerTreatment #GeneticTesting #PatientSafety #HealthcareEducation #Oncology #Pharmacogenomics #DrugSafety #CancerCare #OncologyUpdates #MedicalNews #HealthAwareness
0
1
3
@ArndtVogel @myESMO VIDEO and SLIDES Celecoxib / Celebrex & ctDNA in Colon Cancer CALGB Alliance / SWOG 80702 ASCO GI Jonathan Nowak, MD
0
0
0
@CathyEngMD @jonathan_nowak @ASCO @NateraOncology @OncoAlert @ALLIANCE_org @SWOG VIDEO SLIDES : Celecoxib / Celebrex & ctDNA in Colon Cancer CALGB Alliance / SWOG 80702 ASCO GI Jonathan Nowak, MD
0
0
1
@gantaisaku1105 VIDEO: FGFR2 Mutations and IDH1 Real-World Data Suggests Caution with Immunotherapy in Specific mBTC
0
0
0
@ArndtVogel @myESMO VIDEO INTERVIEW: Pamrevlumab in Metastatic Pancreatic Cancer: Insights from Precision Promise Trial ASCO GI 2025
0
0
0
@KrishanJethwa VIDEO INTERVIEW: Pamrevlumab in Metastatic Pancreatic Cancer: Insights from Precision Promise Trial ASCO GI 2025
0
0
0
@pashtoonkasi @PanCAN @OncoAlert VIDEO INTERVIEW: Pamrevlumab in Metastatic Pancreatic Cancer: Insights from Precision Promise Trial ASCO GI 2025
0
0
1
@ryanhuey VIDEO INTERVIEW: Pamrevlumab in Metastatic Pancreatic Cancer: Insights from Precision Promise Trial ASCO GI 2025
0
0
0